Beyond these novel insights into the impact of EZH2 and KMT2D mutations at the single-cell level in DLBCL, the authors also demonstrated the more general statistical power of these types of datasets by developing new computational analysis pipelines. The gene discussed is KMT2D; the disease is diffuse large B-cell lymphoma.